tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

IONS Stock Latest News

Ionis Pharmaceuticals announces CHMP opinion recommending Dawnzera approval
The FlyIonis Pharmaceuticals announces CHMP opinion recommending Dawnzera approval
2d ago
IONS
Arrowhead price target raised to $45 from $29 at Morgan Stanley
PremiumThe Fly
Arrowhead price target raised to $45 from $29 at Morgan Stanley
4d ago
ARWR
IONS
Ionis Pharmaceuticals announces $700M convertible senior notes offering
PremiumThe Fly
Ionis Pharmaceuticals announces $700M convertible senior notes offering
5d ago
IONS
Ionis Pharmaceuticals’ Olezarsen: Promising Phase 3 Results and Blockbuster Potential Justify Buy Rating
PremiumRatings
Ionis Pharmaceuticals’ Olezarsen: Promising Phase 3 Results and Blockbuster Potential Justify Buy Rating
6d ago
IONS
Ionis Pharmaceuticals Reports Positive Phase 3 Study Results
PremiumCompany Announcements
Ionis Pharmaceuticals Reports Positive Phase 3 Study Results
6d ago
8K
IONS
Ionis Pharmaceuticals price target raised to $110 from $100 at H.C. Wainwright
PremiumThe FlyIonis Pharmaceuticals price target raised to $110 from $100 at H.C. Wainwright
6d ago
IONS
Promising Potential of Ionis Pharmaceuticals’ Olezarsen Drives Buy Rating
Premium
Ratings
Promising Potential of Ionis Pharmaceuticals’ Olezarsen Drives Buy Rating
6d ago
IONS
Ionis Pharmaceuticals announces Phase 3 CORE, CORE2 met primary endpoint
Premium
The Fly
Ionis Pharmaceuticals announces Phase 3 CORE, CORE2 met primary endpoint
7d ago
IONS
Cathie Wood Buys the Dip in Archer Aviation (ACHR) After Weak Q3 Results, Trims Stakes in Roku and TER Stocks
PremiumMarket News
Cathie Wood Buys the Dip in Archer Aviation (ACHR) After Weak Q3 Results, Trims Stakes in Roku and TER Stocks
9d ago
TER
TXG
Ionis Pharmaceuticals presents data on Dawnzera at ACAAI 2025 Annual Meeting
PremiumThe Fly
Ionis Pharmaceuticals presents data on Dawnzera at ACAAI 2025 Annual Meeting
10d ago
IONS
Ionis Pharmaceuticals price target raised to $77 from $70 at Piper Sandler
PremiumThe Fly
Ionis Pharmaceuticals price target raised to $77 from $70 at Piper Sandler
12d ago
IONS
Ionis Pharmaceuticals Faces Investor Risks Amid Market Volatility and Milestone Uncertainties
PremiumCompany Announcements
Ionis Pharmaceuticals Faces Investor Risks Amid Market Volatility and Milestone Uncertainties
16d ago
IONS
Ionis Pharmaceuticals price target raised to $100 from $95 at H.C. Wainwright
PremiumThe FlyIonis Pharmaceuticals price target raised to $100 from $95 at H.C. Wainwright
17d ago
IONS
Ionis Pharmaceuticals price target raised to $94 from $90 at Morgan Stanley
Premium
The Fly
Ionis Pharmaceuticals price target raised to $94 from $90 at Morgan Stanley
17d ago
IONS
Ionis Pharmaceuticals price target raised to $99 from $59 at TD Cowen
Premium
The Fly
Ionis Pharmaceuticals price target raised to $99 from $59 at TD Cowen
17d ago
IONS
Ionis Pharmaceuticals: Strong Q3 Performance and Promising Future Catalysts Support Buy Rating
PremiumRatings
Ionis Pharmaceuticals: Strong Q3 Performance and Promising Future Catalysts Support Buy Rating
17d ago
IONS
Ionis Pharmaceuticals price target raised to $95 from $80 at Barclays
PremiumThe Fly
Ionis Pharmaceuticals price target raised to $95 from $80 at Barclays
17d ago
IONS
Ionis Pharmaceuticals: Strong Q3 Performance and Promising Pipeline Drive Buy Rating
PremiumRatings
Ionis Pharmaceuticals: Strong Q3 Performance and Promising Pipeline Drive Buy Rating
17d ago
IONS
Ionis Pharmaceuticals Reports Strong Q3 2025 Growth
PremiumCompany Announcements
Ionis Pharmaceuticals Reports Strong Q3 2025 Growth
17d ago
IONS
Ionis Pharmaceuticals Shines in Q3 2025 Earnings Call
PremiumCompany AnnouncementsIonis Pharmaceuticals Shines in Q3 2025 Earnings Call
17d ago
IONS
Ionis Pharmaceuticals: Strong Growth Potential and Strategic Advancements Drive Buy Rating
Premium
Ratings
Ionis Pharmaceuticals: Strong Growth Potential and Strategic Advancements Drive Buy Rating
18d ago
IONS
Ionis Pharmaceuticals: A Compelling Buy with Strong Performance and Promising Growth Catalysts
Premium
Ratings
Ionis Pharmaceuticals: A Compelling Buy with Strong Performance and Promising Growth Catalysts
18d ago
IONS

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >